Flipping the switches: CD40 and CD45 modulation of microglial activation states in HIV associated dementia (HAD)

Molecular Neurodegeneration

Volumn 6, Issue 1, 2011, Pages

  Salemi, Jon ^a   Obregon, Demian F ^a   Cobb, Anthony ^a   Reed, Spenser ^a   Sadic, Edin ^a   Jin, Jingji ^a   Fernandez, Francisco ^a   Tan, Jun ^a   Giunta, Brian ^a  

^a UNIVERSITY OF SOUTH FLORIDA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID BETA PROTEIN; AMYLOID PRECURSOR PROTEIN; CD40 ANTIGEN; CD40 LIGAND; CD45 ANTIGEN; GAMMA INTERFERON; INDOLEAMINE 2,3 DIOXYGENASE; INTERLEUKIN 1; INTERLEUKIN 10; INTERLEUKIN 12; NITRIC OXIDE; SUPPRESSOR OF CYTOKINE SIGNALING; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA;

ANTIGEN PRESENTING CELL; BLOOD BRAIN BARRIER; BRAIN ATROPHY; CD4+ T LYMPHOCYTE; CELL ACTIVATION; CYTOKINE PRODUCTION; DRUG TARGETING; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HIV ASSOCIATED DEMENTIA; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; LYMPHOCYTE COUNT; MACROPHAGE; MICROGLIA; MONOCYTE; NEUROPATHOLOGY; NONHUMAN; PATHOGENESIS; PHAGOCYTOSIS; PHENOTYPE; REVIEW;

EID: 78651081983     PISSN: None     EISSN: 17501326     Source Type: Journal    
DOI: 10.1186/1750-1326-6-3     Document Type: Review

References (139)

1. Role of macrophages/microglia in multiple sclerosis and experimental allergic encephalomyelitis. EN Benveniste, J Mol Med 1997 75 3 165 73 10.1007/s001090050101 9106073
2. Cytotoxicity of microglia. RB Banati J Gehrmann P Schubert GW Kreutzberg, Glia 1993 7 1 111 8 10.1002/glia.440070117 8423058
3. Complement and cytokine gene expression in cultured microglial derived from postmortem human brains. DG Walker SU Kim PL McGeer, J Neurosci Res 1995 40 4 478 93 10.1002/jnr.490400407 7616608
4. Class II MHC gene expression in microglia. Regulation by the cytokines IFN-gamma, TNF-alpha, and TGF-beta. RB Panek EN Benveniste, J Immunol 1995 154 6 2846 54 7876554
5. Antigen presentation and tumor cytotoxicity by interferon-gamma-treated microglial cells. K Frei C Siepl P Groscurth S Bodmer C Schwerdel A Fontana, Eur J Immunol 1987 17 9 1271 8 10.1002/eji.1830170909 3115791
6. MHC antigen expression on bulk isolated macrophage-microglia from newborn mouse brain: induction of Ia antigen expression by gamma-interferon. A Suzumura SG Mezitis NK Gonatas DH Silberberg, J Neuroimmunol 1987 15 3 263 78 10.1016/0165-5728(87)90121-4 3110208
7. Biology of adult human microglia in culture: comparisons with peripheral blood monocytes and astrocytes. K Williams A Bar-Or E Ulvestad A Olivier JP Antel VW Yong, J Neuropathol Exp Neurol 1992 51 5 538 49 10.1097/00005072- 199209000-00009 1517774
8. The many faces of macrophage activation. DM Mosser, J Leukoc Biol 2003 73 2 209 12 10.1189/jlb.0602325 12554797
9. Monocyte and macrophage heterogeneity. S Gordon PR Taylor, Nat Rev Immunol 2005 5 12 953 64 10.1038/nri1733 16322748
10. Pro-inflammatory and pro-oxidant properties of the HIV protein Tat in a microglial cell line: attenuation by 17 beta-estradiol. AJ Bruce-Keller SW Barger NI Moss JT Pham JN Keller A Nath, J Neurochem 2001 78 6 1315 24 10.1046/j.1471-4159.2001.00511.x 11579140
11. TLR3 and TLR4 are innate antiviral immune receptors in human microglia: role of IRF3 in modulating antiviral and inflammatory response in the CNS. HS Suh ML Zhao N Choi TJ Belbin CF Brosnan SC Lee, Virology 2009 392 2 246 59 10.1016/j.virol.2009.07.001 19646728
12. Suppressor of cytokine signaling 3 inhibits antiviral IFN-beta signaling to enhance HIV-1 replication in macrophages. LN Akhtar MY Tahir F Ahmed I Ul-Haq KP Salim, J Immunol 185 4 2393 404 10.4049/jimmunol.0903563 20631305
13. IFN-beta-induced SOCS-1 negatively regulates CD40 gene expression in macrophages and microglia. H Qin CA Wilson SJ Lee EN Benveniste, Faseb J 2006 20 7 985 7 10.1096/fj.05-5493fje 16571771
14. The role of macrophage/microglia and astrocytes in the pathogenesis of three neurologic disorders: HIV-associated dementia, Alzheimer disease, and multiple sclerosis. A Minagar P Shapshak R Fujimura R Ownby M Heyes C Eisdorfer, J Neurol Sci 2002 202 1-2 13 23 10.1016/S0022-510X(02)00207-1 12220687
15. T cell immunity induced by allogeneic microglia in relation to neuronal retina transplantation. N Ma JW Streilein, J Immunol 1999 162 8 4482 9 10201985
16. Microglia induce CD4 T lymphocyte final effector function and death. AL Ford E Foulcher FA Lemckert JD Sedgwick, J Exp Med 1996 184 5 1737 45 10.1084/jem.184.5.1737 8920862
17. Cytokines and arachidonic metabolites produced during human immunodeficiency virus (HIV)-infected macrophage-astroglia interactions: implications for the neuropathogenesis of HIV disease. P Genis M Jett EW Bernton T Boyle HA Gelbard K Dzenko RW Keane L Resnick Y Mizrachi DJ Volsky,, et al. J Exp Med 1992 176 6 1703 18 10.1084/jem.176.6.1703 1460427
18. Mononuclear phagocyte immunity and the neuropathogenesis of HIV-1 infection. Y Persidsky HE Gendelman, J Leukoc Biol 2003 74 5 691 701 10.1189/jlb.0503205 14595004
19. Neuronal apoptosis does not correlate with dementia in HIV infection but is related to microglial activation and axonal damage. HF Adle-Biassette L Chretien C Wingertsmann T Hery F Ereau M Scaravilli F Tardieu Gray, Neuropathol Appl Neurobiol 1999 25 123 133 10.1046/j.1365-2990.1999.00167.x 10216000
20. Role of microglia in inflammation-mediated neurodegenerative diseases: mechanisms and strategies for therapeutic intervention. BHJ Liu, J Pharm Exp Ther 2003 304 1 7 10.1124/jpet.102.035048 (Pubitemid 36008905)
21. Microglia-mediated neurotoxicity: uncovering the molecular mechanisms. Z.L BlockML JS Hong, Nat Rev Neurosci 2007 8 57 69 10.1038/nrn2038 17180163
22. Disruption of neuronal autophagy by infected microglia results in neurodegeneration. MKW Alirezaei CT Flynn NR Brady HS Fox, PLoS ONE 2008 3 2906 10.1371/journal.pone.0002906 18682838
23. Decreased neuronal autophagy in HAD: a mechanism of indirect neurotoxicity. MKW Alirezaei HS Fox, Autophagy 2008 1 4(7) 963 969
24. Neuroimaging correlates of HIV-associated BBB compromise. MJ Avison A Nath R Greene-Avison FA Schmitt RN Greenberg JR Berger, J Neuroimmunol 2004 157 1-2 140 6 10.1016/j.jneuroim.2004.08.025 15579291
25. Pathological correlates of cognitive decline in Alzheimer's disease. K Thind MN Sabbagh, Panminerva Med 2007 49 4 191 5 18091671
26. Head injuries in Alzheimer's disease and vascular dementia. R Sulkava T Erkinjuntti J Palo, Neurology 1985 35 12 1804 4069379
27. Human brain parenchymal microglia express CD14 and CD45 and are productively infected by HIV-1 in HIV-1 encephalitis. MA Cosenza ML Zhao Q Si SC Lee, Brain Pathol 2002 12 4 442 55 10.1111/j.1750-3639.2002.tb00461.x 12408230
28. NeuroAIDS: contributions of the human immunodeficiency virus-1 proteins Tat and gp120 as well as CD40 to microglial activation. TG D'Aversa E.A Eugenin JW Berman, J Neurosci Res 2005 81 3 436 46 15954144
29. Inflammatory changes and breakdown of microvascular integrity in early human immunodeficiency virus dementia. MJ Avison A Nath R Greene-Avison FA Schmitt RA Bales A Ethisham RN Greenberg JR Berger, J Neurovirol 2004 10 4 223 32 10.1080/13550280490463532 15371152
30. Subcortical infarcts, Alzheimer's disease pathology, and memory function in older persons. JA Schneider PA Boyle Z Arvanitakis JL Bienias DA Bennett, Ann Neurol 2007 62 1 59 66 10.1002/ana.21142 17503514
31. Mechanical stress and formation of protein aggregates in neurodegenerative disorders. NS Hachiya Y Kozuka K Kaneko, Med Hypotheses 2008 70 5 1034 7 10.1016/j.mehy.2007.06.043 17910993
32. The coming problem of HIV-associated Alzheimer's disease. JM Alisky, Med Hypotheses 2007 69 5 1140 3 10.1016/j.mehy.2007.02.030 17433562
33. HIV in older adults. MJ Simone J Appelbaum, Geriatrics 2008 63 12 6 12 19061274
34. Psychopharmacology in HIV-infected patients. MJ Repetto JM Petitto, Psychosom Med 2008 70 5 585 92 10.1097/PSY.0b013e3181777190 18519881
35. Pathogenesis of Human Immunodeficiency Virus Type-1 (HIV-1)-Associated Dementia: Role of Voltage-Gated Potassium Channels. JP Keblesh BC Reiner J Liu H Xiong, Retrovirology 2008 2 1 10 20651955
36. Neurobiology of HIV. B Hult G Chana E Masliah I Everall, Int Rev Psychiatry 2008 20 1 3 13 10.1080/09540260701862086 18240058
37. HIV-1 TAT inhibits microglial phagocytosis of Abeta peptide. B Giunta Y Zhou H Hou E Rrapo F Fernandez J Tan, Int J Clin Exp Pathol 2008 1 3 260 75 18784813
38. Age, apolipoprotein E4, and the risk of HIV dementia: the Hawaii Aging with HIV Cohort. V Valcour C Shikuma B Shiramizu M Watters P Poff OA Selnes J Grove Y Liu KB Abdul-Majid S Gartner N Sacktor, J Neuroimmunol 2004 157 1-2 197 202 10.1016/j.jneuroim.2004.08.029 15579298 (Pubitemid 39576655)
39. Brain deposition of beta-amyloid is a common pathologic feature in HIV positive patients. DA Green E Masliah HV Vinters P Beizai DJ Moore CL Achim, Aids 2005 19 4 407 11 10.1097/01.aids.0000161770.06158.5c 15750394
40. Microglia and inflammatory mechanisms in the clearance of amyloid beta peptide. J Rogers R Strohmeyer CJ Kovelowski R Li, Glia 2002 40 2 260 9 10.1002/glia.10153 12379913
41. Microglial chemotaxis, activation, and phagocytosis of amyloid beta-peptide as linked phenomena in Alzheimer's disease. J Rogers LF Lue, Neurochem Int 2001 39 5-6 333 40 10.1016/S0197-0186(01)00040-7 11578768
42. Prevalence of Alzheimer plaques in AIDS. MM Esiri S.C Biddolph CS Morris, J Neurol Neurosurg Psychiatry 1998 65 1 29 33 10.1136/jnnp.65.1.29 9667557
43. HIV-1 Tat contributes to Alzheimer's disease-like pathology in PSAPP mice. B Giunta H Hou Y Zhu E Rrapo J Tian M Takashi D Commins E Singer J He F Fernandez J Tan, Int J Clin Exp Pathol 2009 2 5 433 43 19294002
44. Neuronal number and volume alterations in the neocortex of HIV infected individuals. IP Everall PJ Luthert PL Lantos, J Neurol Neurosurg Psychiatry 1993 56 5 481 6 10.1136/jnnp.56.5.481 8505639
45. The neuropathology of adult HIV infection. JE Bell, Rev Neurol (Paris) 1998 154 12 816 29 9932303
46. Neuronal apoptosis in HIV infection in adults. H Adle-Biassette Y Levy M Colombel F Poron S Natchev C Keohane F Gray, Neuropathol Appl Neurobiol 1995 21 3 218 27 10.1111/j.1365-2990.1995.tb01053.x 7477730
47. CSF tau and Abeta42: logical biomarkers for Alzheimer's disease? D Galasko, Neurobiol Aging 1998 19 2 117 9 10.1016/S0197-4580(98)00021-9 9558144
48. Reduction of beta-amyloid peptide42 in the cerebrospinal fluid of patients with Alzheimer's disease. R Motter C Vigo-Pelfrey D Kholodenko R Barbour K Johnson-Wood D Galasko L Chang B Miller C Clark R Green,, et al. Ann Neurol 1995 38 4 643 8 10.1002/ana.410380413 7574461
49. CSF amyloid beta42 and tau levels correlate with AIDS dementia complex. BJ Brew L Pemberton K Blennow A Wallin L Hagberg, Neurology 2005 65 9 1490 2 10.1212/01.wnl.0000183293.95787.b7 16275845
50. Cerebrospinal fluid tau and Abeta42 as predictors of development of Alzheimer's disease in patients with mild cognitive impairment. N Andreasen L Minthon E Vanmechelen H Vanderstichele P Davidsson B Winblad K Blennow, Neurosci Lett 1999 273 1 5 8 10.1016/S0304-3940(99)00617-5 10505638
51. The AIDS dementia complex: I. Clinical features. BA Navia BD Jordan RW Price, Ann Neurol 1986 19 6 517 24 10.1002/ana.410190602 3729308
52. The neurobiology of human immunodeficiency virus infections. RT Johnson JC McArthur O Narayan, Faseb J 1988 2 14 2970 81 2846395
53. Implications of the kynurenine pathway and quinolinic acid in Alzheimer's disease. GJ Guillemin BJ Brew, Redox Rep 2002 7 4 199 206 10.1179/ 135100002125000550 12396664
54. Nitric oxide: first in a new class of neurotransmitters. SH Snyder, Science 1992 257 5069 494 6 10.1126/science.1353273 1353273
55. Quinolinic acid in cerebrospinal fluid and serum in HIV-1 infection: relationship to clinical and neurological status. MP Heyes BJ Brew A Martin RW Price AM Salazar JJ Sidtis JA Yergey MM Mouradian AE Sadler J Keilp,, et al. Ann Neurol 1991 29 2 202 9 10.1002/ana.410290215 1826418
56. Increased ratio of quinolinic acid to kynurenic acid in cerebrospinal fluid of D retrovirus-infected rhesus macaques: relationship to clinical and viral status. MP Heyes IN Mefford BJ Quearry M Dedhia A Lackner, Ann Neurol 1990 27 6 666 75 10.1002/ana.410270614 2163238
57. Cerebrospinal fluid quinolinic acid concentrations are increased in acquired immune deficiency syndrome. MP Heyes D Rubinow C Lane SP Markey, Ann Neurol 1989 26 2 275 7 10.1002/ana.410260215 2528321
58. Quinolinic acid and kynurenine pathway metabolism in inflammatory and non-inflammatory neurological disease. MP Heyes K Saito JS Crowley LE Davis MA Demitrack M Der LA Dilling J Elia MJ Kruesi A Lackner,, et al. Brain 1992 115 Pt 5 1249 73 10.1093/brain/115.5.1249 1422788
59. Neurobiological aspects of human immunodeficiency virus infection: neurotoxic mechanisms. A Nath J Geiger, Prog Neurobiol 1998 54 1 19 33 10.1016/S0301-0082(97)00053-1 9460791
60. In vitro evidence for a dual role of tumor necrosis factor-alpha in human immunodeficiency virus type 1 encephalopathy. SG Wilt E Milward JM Zhou K Nagasato H Patton R Rusten DE Griffin M O'Connor M Dubois-Dalcq, Ann Neurol 1995 37 3 381 94 10.1002/ana.410370315 7695238
61. Cellular localization of tumor necrosis factor mRNA in neurological tissue from HIV-infected patients by combined reverse transcriptase/polymerase chain reaction in situ hybridization and immunohistochemistry. SL Wesselingh K Takahashi JD Glass JC McArthur JW Griffin DE Griffin, J Neuroimmunol 1997 74 1-2 1 8 10.1016/S0165-5728(96)00160-9 9119960
62. Induction of tryptophan degradation in vitro and in vivo: a gamma-interferon-stimulated activity. GI Byrne LK Lehmann JG Kirschbaum EC Borden CM Lee RR Brown, J Interferon Res 1986 6 4 389 96 3095441
63. Negative correlation between blood cell counts and serum neopterin concentration in patients with HIV-1 infection. D Fuchs GM Shearer RN Boswell DR Lucey M Clerici G Reibnegger ER Werner RA Zajac H Wachter, Aids 1991 5 2 209 12 10.1097/00002030-199102000-00012 1674419
64. Human macrophages degrade tryptophan upon induction by interferon-gamma. ER Werner G Bitterlich D Fuchs A Hausen G Reibnegger G Szabo MP Dierich H Wachter, Life Sci 1987 41 3 273 80 10.1016/0024-3205(87)90149-4 3110526
65. Human immunodeficiency virus type 1 infection alters chemokine beta peptide expression in human monocytes: implications for recruitment of leukocytes into brain and lymph nodes. H Schmidtmayerova HS Nottet G Nuovo T Raabe CR Flanagan L Dubrovsky HE Gendelman A Cerami M Bukrinsky B Sherry, Proc Natl Acad Sci USA 1996 93 2 700 4 10.1073/pnas.93.2.700 8570619
66. Morphology and distribution of HIV-1 gp41-positive microglia in subacute AIDS encephalitis. Pattern of involvement resembling a multisystem degeneration. K Kure KM Weidenheim WD Lyman DW Dickson, Acta Neuropathol 1990 80 4 393 400 10.1007/BF00307693 2239151
67. [The morphology of HIV encephalopathy]. F Gullotta K Kuchelmeister T Masini P Ghidoni E Cappricci, Zentralbl Allg Pathol 1989 135 1 5 13 2929183
68. Monocyte/macrophage trafficking in acquired immunodeficiency syndrome encephalitis: lessons from human and nonhuman primate studies. T Fischer-Smith C Bell S Croul M Lewis J Rappaport, J Neurovirol 2008 14 4 318 26 10.1080/13550280802132857 18780233
69. Molecular mechanisms of neuroinvasion by monocytes-macrophages in HIV-1 infection. G Gras M Kaul, Retrovirology 7 30 10.1186/1742-4690-7-30 20374632
70. Microglial nodule encephalitis: limited CNS infection despite disseminated systemic cryptococcosis. M Edelman MC Birkenhauer JJ Steinberg DW Dickson A Casadevall SC Lee, Clin Neuropathol 1996 15 1 30 3 8998854
71. Microglial and astrocyte chemokines regulate monocyte migration through the blood-brain barrier in human immunodeficiency virus-1 encephalitis. Y Persidsky A Ghorpade J Rasmussen J Limoges XJ Liu M Stins M Fiala D Way KS Kim MH Witte M Weinand L Carhart HE Gendelman, Am J Pathol 1999 155 5 1599 611 10550317
72. Microglia in diseases of the central nervous system. PT Nelson LA Soma E Lavi, Ann Med 2002 34 7-8 491 500 10.1080/078538902321117698 12553488
73. Microglia in the giant cell encephalitis of acquired immune deficiency syndrome: proliferation, infection and fusion. J Michaels RW Price MK Rosenblum, Acta Neuropathol 1988 76 4 373 9 10.1007/BF00686974 3176903
74. Effects of antiretroviral therapy on cognitive impairment. KJ Liner CD Hall KR Robertson, Curr HIV/AIDS Rep 2008 5 2 64 71 10.1007/s11904-008-0011-7 18510891
75. Diagnosis and treatment of HIV-associated neurocognitive disorders. SJ Ferrando, New Dir Ment Health Serv 2000 87 25 35 10.1002/yd.23320008705 11031798
76. HIV infection of the central nervous system: clinical features and neuropathogenesis. L Boisse MJ Gill C Power, Neurol Clin 2008 26 3 799 819 x 10.1016/j.ncl.2008.04.002 18657727
77. Amyloid fibril toxicity in Alzheimer's disease and diabetes. A Lorenzo BA Yankner, Ann N Y Acad Sci 1996 777 89 95 10.1111/j.1749-6632.1996.tb34406.x 8624132
78. Beta-amyloid neurotoxicity requires fibril formation and is inhibited by congo red. A Lorenzo BA Yankner, Proc Natl Acad Sci USA 1994 91 25 12243 7 10.1073/pnas.91.25.12243 7991613
79. Exposure of rat hippocampal neurons to amyloid beta peptide (25-35) induces the inactivation of phosphatidyl inositol-3 kinase and the activation of tau protein kinase I/glycogen synthase kinase-3 beta. A Takashima K Noguchi G Michel M Mercken M Hoshi K Ishiguro K Imahori, Neurosci Lett 1996 203 1 33 6 10.1016/0304-3940(95)12257-5 8742040
80. EGCG mitigates neurotoxicity mediated by HIV-1 proteins gp120 and Tat in the presence of IFN-gamma: role of JAK/STAT1 signaling and implications for HIV-associated dementia. B Giunta D Obregon H Hou J Zeng N Sun V Nikolic J Ehrhart D Shytle F Fernandez J Tan, Brain Res 2006 1123 1 216 25 10.1016/j.brainres.2006.09.057 17078933
81. Senile plaques stimulate microglia to release a neurotoxin found in Alzheimer brain. D Giulian LJ Haverkamp J Li WL Karshin J Yu D Tom X Li JB Kirkpatrick, Neurochem Int 1995 27 1 119 37 10.1016/0197-0186(95)00067-I 7655344
82. CD45 inhibits CD40L-induced microglial activation via negative regulation of the Src/p44/42 MAPK pathway. J Tan T Town M Mullan, J Biol Chem 2000 275 47 37224 31 10.1074/jbc.M002006200 10978311
83. Reactive microglia are positive for HLA-DR in the substantia nigra of Parkinson's and Alzheimer's disease brains. PL McGeer S Itagaki BE Boyes EG McGeer, Neurology 1988 38 8 1285 91 3399080
84. The role of the immune system in neurodegenerative disorders. EG McGeer PL McGeer, Mov Disord 1997 12 6 855 8 10.1002/mds.870120604 9399206
85. Reactions of the immune system in chronic degenerative neurological diseases. PL McGeer EG McGeer T Kawamata T Yamada H Akiyama, Can J Neurol Sci 1991 18 3 Suppl 376 9 1933684
86. Role of microglia in plaque formation in senile dementia of the Alzheimer type. An immunohistochemical study. JM Rozemuller P Eikelenboom FC Stam, Virchows Arch B Cell Pathol Incl Mol Pathol 1986 51 3 247 54 10.1007/BF02899034 2874657
87. Microglial cells around amyloid plaques in Alzheimer's disease express leucocyte adhesion molecules of the LFA-1 family. JM Rozemuller P Eikelenboom ST Pals FC Stam, Neurosci Lett 1989 101 3 288 92 10.1016/0304-3940(89)90547-8 2549464
88. Nuclear factor-kappa B family member RelB inhibits human immunodeficiency virus-1 Tat-induced tumor necrosis factor-alpha production. M Kiebala O Polesskaya Z Yao SW Perry SB Maggirwar, PLoS One 5 7 11875 10.1371/journal.pone. 0011875 20686703
89. Molecular pathway involved in HIV-1-induced CNS pathology: role of viral regulatory protein, Tat. J Rappaport J Joseph S Croul G Alexander L Del Valle S Amini K Khalili, J Leukoc Biol 1999 65 4 458 65 10204574
90. Ultrastructural studies of the cells forming amyloid fibers in classical plaques. HM Wisniewski J Wegiel KC Wang M Kujawa B Lach, Can J Neurol Sci 1989 16 4 Suppl 535 42 2553231
91. Interaction of Alzheimer beta-amyloid peptide with the human monocytic cell line THP-1 results in a protein kinase C-dependent secretion of tumor necrosis factor-alpha. A Klegeris DG Walker PL McGeer, Brain Res 1997 747 1 114 21 10.1016/S0006-8993(96)01229-2 9042534
92. beta-amyloid protein enhances macrophage production of oxygen free radicals and glutamate. A Klegeris PL McGeer, J Neurosci Res 1997 49 2 229 35 10.1002/(SICI)1097-4547(19970715)49:2<229::AID-JNR11>3.0.CO;2-W 9272645
93. Activation of macrophages by Alzheimer beta amyloid peptide. A Klegeris DG Walker PL McGeer, Biochem Biophys Res Commun 1994 199 2 984 91 10.1006/bbrc.1994.1326 7510964
94. Amyloid fibrils activate tyrosine kinase-dependent signaling and superoxide production in microglia. DR McDonald KR Brunden GE Landreth, J Neurosci 1997 17 7 2284 94 9065490
95. beta-Amyloid fibrils activate parallel mitogen-activated protein kinase pathways in microglia and THP1 monocytes. DR McDonald ME Bamberger CK Combs GE Landreth, J Neurosci 1998 18 12 4451 60 9614222
96. Identification of microglial signal transduction pathways mediating a neurotoxic response to amyloidogenic fragments of beta-amyloid and prion proteins. CK Combs DE Johnson SB Cannady TM Lehman GE Landreth, J Neurosci 1999 19 3 928 39 9920656
97. CD40 signaling regulates innate and adaptive activation of microglia in response to amyloid beta-peptide. KP Townsend T Town T Mori LF Lue D Shytle PR Sanberg D Morgan F Fernandez RA Flavell J Tan, Eur J Immunol 2005 35 3 901 10 10.1002/eji.200425585 15688347
98. beta-Amyloid induces increased release of interleukin-1 beta from lipopolysaccharide-activated human monocytes. D Lorton JM Kocsis L King K Madden KR Brunden, J Neuroimmunol 1996 67 1 21 9 8707927
99. Neurotrophic and neurotoxic effects of amyloid beta protein: reversal by tachykinin neuropeptides. BA Yankner LK Duffy DA Kirschner, Science 1990 250 4978 279 82 10.1126/science.2218531 2218531
100. NADPH oxidase drives cytokine and neurotoxin release from microglia and macrophages in response to HIV-Tat. J Turchan-Cholewo VM Dimayuga S Gupta RM Gorospe JN Keller AJ Bruce-Keller, Antioxid Redox Signal 2009 11 2 193 204 10.1089/ars.2008.2097 18715150
101. HIV type 1 glycoprotein 120 amplifies tumor necrosis factor-induced NF-kappa B activation in Jurkat cells. VA Shatrov F Ratter A Gruber W Droge V Lehmann, AIDS Res Hum Retroviruses 1996 12 13 1209 16 10.1089/aid.1996.12.1209 8870842
102. Morphine and HIV-Tat increase microglial-free radical production and oxidative stress: possible role in cytokine regulation. J Turchan-Cholewo FO Dimayuga S Gupta JN Keller PE Knapp KF Hauser AJ Bruce-Keller, J Neurochem 2009 108 1 202 15 10.1111/j.1471-4159.2008.05756.x 19054280
103. Temporal relationships between HIV-1 Tat-induced neuronal degeneration, OX-42 immunoreactivity, reactive astrocytosis, and protein oxidation in the rat striatum. MY Aksenov U Hasselrot G Wu A Nath C Anderson CF Mactutus RM Booze, Brain Res 2003 987 1 1 9 10.1016/S0006-8993(03)03194-9 14499939
104. The emerging role of CD40 ligand in HIV infection. RS Kornbluth, J Leukoc Biol 2000 68 3 373 82 10985254
105. Impact of the CD40-CD40L dyad in Alzheimer's disease. B Giunta K Rezai-Zadeh J Tan, CNS Neurol Disord Drug Targets 9 2 149 55 20205645
106. Soluble Cd40 Ligand in Dementia. B Giunta KP Figueroa T Town J Tan, Drugs Future 2009 34 4 333 340 10.1358/dof.2009.034.04.1358595 19777117
107. Soluble CD40 ligand in acute coronary syndromes. C Heeschen S Dimmeler CW Hamm MJ van den Brand E Boersma AM Zeiher ML Simoons CAPTURE Study Investigators, N Engl J Med 2003 348 12 1104 11 10.1056/NEJMoa022600 12646667
108. Platelets and cytokines in concert with endothelial activation in patients with peripheral arterial occlusive disease. DA Tsakiris M Tschöpl F Wolf KH Labs KA Jäger GA Marbet, Blood Coagul Fibrinolysis 2000 11 2 165 73 10759010
109. Increased monocytic activity and biomarkers of inflammation in patients with type 1 diabetes. S Devaraj N Glaser S Griffen J Wang-Polagruto E Miguelino I Jialal, Diabetes 2006 55 3 774 9 10.2337/diabetes.55.03.06.db05-1417 16505242
110. CD40 ligand increases expression of its receptor CD40 in human coronary artery endothelial cells. H Chai S Yan H Wang R Zhang PH Lin Q Yao C Chen, Surgery 2006 140 2 236 42 10.1016/j.surg.2006.03.016 16904975
111. CD40-CD40 ligand interactions in experimental allergic encephalomyelitis and multiple sclerosis. K Gerritse JD Laman RJ Noelle A Aruffo JA Ledbetter WJ Boersma E Claassen, Proc Natl Acad Sci USA 1996 93 6 2499 504 10.1073/pnas.93.6.2499 8637903
112. Elevated expression of IFN-gamma in the HIV-1 infected brain. P Shapshak R Duncan A Minagar P Rodriguez de la Vega RV Stewart K Goodkin, Front Biosci 2004 9 1073 81 10.2741/1271 14977530
113. CD40-CD154 interaction and IFN-gamma are required for IL-12 but not prostaglandin E2 secretion by microglia during antigen presentation to Th1 cells. F Aloisi G Penna E Polazzi L Minghetti L Adorini, J Immunol 1999 162 3 1384 91 9973393
114. Post-transcriptional inhibition of CD40 gene expression in microglia by transforming growth factor-beta. VT Nguyen WS Walker EN Benveniste, Eur J Immunol 1998 28 8 2537 48 10.1002/(SICI)1521-4141(199808)28:08<2537::AID- IMMU2537>3.0.CO;2-1 9710231
115. Expression of CD40 in the brain of Alzheimer's disease and other neurological diseases. T Togo H Akiyama H Kondo K Ikeda M Kato E Iseki K Kosaka, Brain Res 2000 885 1 117 21 10.1016/S0006-8993(00)02984-X 11121537
116. Alzheimer's beta-amyloid peptides induce inflammatory cascade in human vascular cells: the roles of cytokines and CD40. Z Suo J Tan A Placzek F Crawford C Fang M Mullan, Brain Res 1998 807 1-2 110 7 10.1016/S0006-8993(98) 00780-X 9757011
117. Microglial activation resulting from CD40-CD40L interaction after beta-amyloid stimulation. J Tan T Town D Paris T Mori Z Suo F Crawford MP Mattson RA Flavell M Mullan, Science 1999 286 5448 2352 5 10.1126/science.286. 5448.2352 10600748
118. Induction of CD40 on human endothelial cells by Alzheimer's beta-amyloid peptides. J Tan A Placzek F Crawford C Fang M Mullan, Brain Res Bull 1999 50 2 143 8 10.1016/S0361-9230(99)00122-7 10535333
119. Expression of functional CD40 by vascular endothelial cells. D Hollenbaugh N Mischel-Petty CP Edwards JC Simon RW Denfeld PA Kiener A Aruffo, J Exp Med 1995 182 1 33 40 10.1084/jem.182.1.33 7540655
120. CD40 on human endothelial cells: inducibility by cytokines and functional regulation of adhesion molecule expression. K Karmann CC Hughes J Schechner WC Fanslow JS Pober, Proc Natl Acad Sci USA 1995 92 10 4342 6 10.1073/pnas.92.10. 4342 7538666
121. HIV-1 induction of CD40 on endothelial cells promotes the outgrowth of AIDS-associated B-cell lymphomas. AV Moses SE Williams JG Strussenberg ML Heneveld RA Ruhl AC Bakke GC Bagby JA Nelson, Nat Med 1997 3 11 1242 9 10.1038/nm1197-1242 9359699
122. Functional synergy between CD40 ligand and HIV-1 Tat contributes to inflammation: implications in HIV type 1 dementia. Z Sui LF Sniderhan G Schifitto RP Phipps HA Gelbard S Dewhurst SB Maggirwar, J Immunol 2007 178 5 3226 36 17312171
123. MRP (ABCC) transporters-mediated efflux of anti-HIV drugs, saquinavir and zidovudine, from human endothelial cells. M Eilers U Roy D Mondal, Exp Biol Med (Maywood) 2008 233 9 1149 60 10.3181/0802-RM-59 18535159
124. Levels of soluble CD40 ligand (CD154) in serum are increased in human immunodeficiency virus type 1-infected patients and correlate with CD4(+) T-cell counts. NV Sipsas pp Sfikakis A Kontos T Kordossis, Clin Diagn Lab Immunol 2002 9 3 558 61 11986259
125. Role of CD40-CVD40L in mouse severe malaria. PF Piguet CD Kan C Vesin A Rochat Y Donati C Barazzone, Am J Pathol 2001 159 2 733 42 11485931
126. CD40/CD40 ligand signaling in mouse cerebral microvasculature after focal ischemia/reperfusion. M Ishikawa T Vowinkel KY Stokes TV Arumugam G Yilmaz A Nanda DN Granger, Circulation 2005 111 13 1690 6 10.1161/01.CIR.0000160349. 42665.0C 15795333
127. CD40-CD40 ligand interactions promote trafficking of CD8+ T cells into the brain and protection against West Nile virus encephalitis. E Sitati EE McCandless RS Klein MS Diamond, J Virol 2007 81 18 9801 11 10.1128/JVI.00941-07 17626103
128. Dyad of CD40/CD40 ligand fosters neuroinflammation at the blood-brain barrier and is regulated via JNK signaling: implications for HIV-1 encephalitis. SH Ramirez S Fan H Dykstra N Reichenbach L Del Valle R Potula RP Phipps SB Maggirwar Y Persidsky, J Neurosci 30 28 9454 64 20631174
129. Ligation of microglial CD40 results in p44/42 mitogen-activated protein kinase-dependent TNF-alpha production that is opposed by TGF-beta 1 and IL-10. J Tan T Town M Saxe D Paris Y Wu M Mullan, J Immunol 1999 163 12 6614 21 10586056
130. Behavioral effects of CD40-CD40L pathway disruption in aged PSAPP mice. J Todd Roach CH Volmar S Dwivedi T Town R Crescentini F Crawford J Tan M Mullan, Brain Res 2004 1015 1-2 161 8 10.1016/j.brainres.2004.05.004 15223380
131. CD45 opposes beta-amyloid peptide-induced microglial activation via inhibition of p44/42 mitogen-activated protein kinase. J Tan T Town T Mori Y Wu M Saxe F Crawford M Mullan, J Neurosci 2000 20 20 7587 94 11027218
132. CD45 regulated signaling pathways. J Irie-Sasaki T Sasaki JM Penninger, Curr Top Med Chem 2003 3 7 783 96 10.2174/1568026033452339 12678844
133. CD45 is a JAK phosphatase and negatively regulates cytokine receptor signalling. J Irie-Sasaki T Sasaki W Matsumoto A Opavsky M Cheng G Welstead E Griffiths C Krawczyk CD Richardson K Aitken N Iscove G Koretzky P Johnson P Liu DM Rothstein JM Penninger, Nature 2001 409 6818 349 54 10.1038/35053086 11201744
134. Effects of CD45 on NF-kappa B. Implications for replication of HIV-1. A Baur S Garber BM Peterlin, J Immunol 1994 152 3 976 83 7905504
135. Attenuation of AD-like neuropathology by harnessing peripheral immune cells: local elevation of IL-10 and MMP-9. M Koronyo-Hamaoui MK Ko Y Koronyo D Azoulay A Seksenyan G Kunis M Pham J Bakhsheshian P Rogeri KL Black DL Farkas M Schwartz, J Neurochem 2009 111 6 1409 24 10.1111/j.1471-4159.2009.06402.x 19780903
136. CD45 isoform RB as a molecular target to oppose lipopolysaccharide- induced microglial activation in mice. KP Townsend M Vendrame J Ehrhart B Faza J Zeng T Town J Tan, Neurosci Lett 2004 362 1 26 30 10.1016/j.neulet.2004.01.082 15147773
137. Abnormalities of CD45 isoform expression in HIV infection. M Mahalingam A Pozniak TJ McManus G Senaldi D Vergani M Peakman, Clin Immunol Immunopathol 1996 81 2 210 4 10.1006/clin.1996.0178 8906753
138. Impaired CD45-associated tyrosine phosphatase activity during HIV-1 infection: implications for CD3 and CD4 receptor signalling. C Guntermann N Amft BJ Murphy KE Nye, Biochem Biophys Res Commun 1998 252 1 69 77 10.1006/bbrc.1998.9595 9813148
139. Anti-CD45RO suppresses human immunodeficiency virus type 1 replication in microglia: role of Hck tyrosine kinase and implications for AIDS dementia. MO Kim HS Suh Q Si BI Terman SC Lee, J Virol 2006 80 1 62 72 10.1128/JVI.80.1.62- 72.2006 16352531